Correlation Between Change in Psoriasis Area and Severity Index and Dermatology Life Quality Index in Patients with Psoriasis: Pooled Analysis from Four Phase 3 Clinical Trials of Secukinumab. [PDF]
Dermatol Ther (Heidelb), 2021 Houghton K +3 more
europepmc +1 more source
Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives. [PDF]
, 2019 Tofacitinib is an oral Janus kinase inhibitor approved for the treatment of psoriatic arthritis (PsA). It provides an alternative option for patients who have had an inadequate response and tolerance to other disease modifying antirheumatic drugs (DMARDs)
Beck, Kristen M +4 more
core
Erectile dysfunction and associated factors in males with psoriasis: a case-control study
Dermatology ReportsPsoriasis is a chronic inflammatory skin disease associated with multiple comorbidities, including erectile dysfunction (ED). Data on the sexual health of male psoriasis patients in Vietnam are limited.
Luan Vi Huynh +3 more
doaj +1 more source
Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion method. [PDF]
J Eur Acad Dermatol Venereol, 2021 Mrowietz U +7 more
europepmc +1 more source
Tildrakizumab in the treatment of psoriasis: latest evidence and place in therapy. [PDF]
, 2019 Psoriasis is a chronic inflammatory disorder that is clinically characterized by scaly cutaneous plaques. New evidence suggests that dysregulation of interleukin (IL)-23, a key cytokine in the T-helper-17 pathway, plays a vital role in the development of
Lee, Erica B +4 more
core
Psoriasis Area and Severity Index and its Correlation with Liver Function Test
Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical UniversityObjective: To determine Psoriasis Area and Severity Index score and its association with LFT values in patients of psoriasis. Methodology: This cross-sectional study, was done on patients visiting the skin OPD of LUMHS Jamshoro/Hyderabad. Diagnosed patients of Psoriasis, aged between 18 and 50 years and both genders were included.
null Jawed Iqbal +5 more
openaire +1 more source
Evaluation of Psoriasis Area and Severity Index as a Proxy for Bio-markers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment Cycles. [PDF]
Acta Derm Venereol, 2021 Hoffmann JHO +4 more
europepmc +1 more source
Клінічні особливості перебігу псоріазу за наявності метаболічного синдрому [PDF]
, 2014 вивчення особливостей клінічного перебігу псоріазу при наявності метаболічного синдрому (МС). Матеріали та методи. Обстежено 93 хворих з бляшковим псоріазом. Усі пацієнти були розділені на дві групи: 1 група включала 48 хворих на псоріаз з МС (вік 47,8 ±
Вірстюк, Н.Г. +1 more
core
Spotlight on itolizumab in the treatment of psoriasis – current perspectives from India
Psoriasis: Targets and Therapy, 2019 Leelavathy Budamakuntla,1 HV Shree-Lakshmi,1 Akshi Bansal,1 Shankar Kumar Venkatarayaraju2 1Department of Dermatology, Venerology and Leprosy, Bangalore Medical College and Research Institute, Bengaluru, Karnataka 560002, India; 2Department of ...
Budamakuntla L +3 more
doaj
5-hydroxymethylcytosine is a key epigenetic regulator of keratinocyte stem cells during psoriasis pathogenesis [PDF]
, 2019 Epigenetic regulation is now known to play an important role in determining stem cell fate during normal tissue development and disease pathogenesis. In this study, we report loss of 5-hydroxymethylcytosine (5-hmC) mediated by ten-eleven translocation ...
Yuan, Christine Wan-Yin
core